January 2025 in numbers
NHS community prescribing in England (Prescription Cost Analysis).
109,700,318items
Dispensed in January 2025
NHSBSA Prescription Cost Analysis
£952,227,701
Net ingredient cost, January 2025
NHSBSA PCA
Most-dispensed medicines
Download full month (CSV)| Medicine | Items | Net ingredient cost |
|---|---|---|
| Atorvastatin | 6,411,073 | £6,998,306 |
| Amlodipine | 3,473,083 | £3,021,099 |
| Lansoprazole | 3,193,754 | £4,071,652 |
| Omeprazole | 3,108,922 | £8,613,015 |
| Ramipril | 3,050,696 | £3,462,145 |
| Levothyroxine sodium | 2,980,844 | £4,109,963 |
| Bisoprolol fumarate | 2,616,709 | £2,069,408 |
| Colecalciferol | 2,466,183 | £9,408,087 |
| Metformin hydrochloride | 2,310,319 | £7,629,729 |
| Sertraline hydrochloride | 2,166,267 | £4,741,543 |
| Aspirin | 1,740,191 | £1,375,563 |
| Salbutamol | 1,711,192 | £5,508,909 |
Biggest risers
Largest month-on-month rise in items (medicines above 10,000 items).
| Medicine | Items | Change |
|---|---|---|
| Oseltamivir phosphate | 15,441 | +54.3% |
| Neomycin sulfate | 44,323 | +26.3% |
| Diphtheria | 32,102 | +25.5% |
| Hepatitis A | 45,732 | +24.6% |
| Hydrocortisone | 52,561 | +23.9% |
| Typhoid | 55,938 | +23.4% |
| Levonorgestrel | 12,813 | +21.1% |
| Powder thickener - gum based (0913161) | 46,234 | +19.4% |
Biggest fallers
Largest month-on-month fall in items.
| Medicine | Items | Change |
|---|---|---|
| Influenza | 553,351 | −45.2% |
| Other individually formulated bought in preparations | 19,002 | −44.0% |
| Phenazone/lidocaine | 11,963 | −27.8% |
| Erythromycin ethylsuccinate | 13,089 | −25.0% |
| Hypromellose | 31,489 | −13.7% |
| Amoxicillin | 979,969 | −12.9% |
| Prednisolone | 37,279 | −11.6% |
| Timolol and travoprost | 10,713 | −7.5% |